7Baggers
Quarterly
Annual
    Unit: USD2025-07-27 2025-04-27 2025-01-26 2024-10-27 2024-07-28 2024-04-28 2024-01-28 2023-10-29 2022-10-30 2022-07-31 2022-05-01 2022-01-30 2021-05-02 2021-01-31 2020-10-25 2020-07-26 2020-04-26 2020-01-26 2019-10-27 2019-07-28 2019-04-28 2019-01-27 2018-10-28 2018-07-29 2018-04-29 2018-01-28 2017-10-29 2017-07-30 2017-04-30 2017-01-29 2016-10-30 2016-07-31 2016-05-01 2016-01-31 2015-10-25 2015-07-26 2015-04-26 2015-01-25 2014-10-26 2014-07-27 2014-04-27 2014-01-26 2013-10-27 2013-07-28 2013-04-28 2013-01-27 2012-10-28 2012-07-29 2012-04-29 2012-01-29 2011-10-30 2011-07-31 2011-05-01 2011-01-30 2010-10-31 2010-08-01 2010-05-02 
      
    		                                                         
      cash flows from operating activities:
    		                                                         
      net income
    		-27,064,000 19,345,000 39,144,000 -7,586,000 -170,295,000 -23,159,000 -642,357,000 -38,252,000 22,743,000 51,596,000 38,048,000 34,791,000 23,498,000 15,631,000 18,482,000 16,122,000 9,632,000 -4,393,000 17,599,000 5,366,000 13,294,000 13,340,000 12,165,000 25,169,000 12,382,000 -1,297,000 13,338,000 12,564,000 11,821,000 8,019,000 30,776,000 8,979,000 6,887,000 1,247,000 10,705,000 -313,000 -142,000 -15,441,000 17,623,000 17,898,000 7,867,000 -210,808,000 12,453,000 19,112,000 14,777,000 13,118,000 16,590,000 10,022,000 2,209,000 12,388,000 26,979,000 27,138,000 22,582,000 26,003,000 16,105,000 19,662,000 10,802,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                                         
      depreciation and amortization
    		10,314,000 10,190,000 10,288,000 10,140,000 12,567,000 10,504,000 8,864,000 22,539,000 7,323,000 7,330,000 7,668,000 8,206,000 7,420,000 7,660,000 7,926,000 7,740,000 8,541,000 9,311,000 9,727,000 9,719,000 10,824,000 12,307,000 12,792,000 12,087,000 12,453,000 13,205,000 12,701,000 11,792,000 11,301,000                     4,929,000 4,803,000 4,540,000 4,271,000 4,181,000 4,412,000 3,985,000 3,870,000 
      amortization of right-of-use assets
    		1,356,000 1,346,000 1,330,000 1,353,000 1,758,000 1,431,000 1,530,000 1,672,000 1,173,000 1,162,000 1,140,000 1,121,000 1,055,000                                             
      investment impairments and credit loss reserves
    		  0 0 0 1,109,000 1,679,000 1,990,000 29,000 -429,000 24,000 407,000 246,000 1,319,000 335,000 1,485,000 3,630,000                                         
      goodwill impairment
    		      473,800,000 2,266,000                                                  
      accretion of deferred financing costs
    		1,271,000 1,254,000  2,056,000 2,379,000 2,379,000                                                    
      write-off of deferred financing costs
    		364,000 152,000  0                                                      
      loss on extinguishment of debt
    		  0 0                                                      
      interest rate swap termination
    		-743,000 14,000                                                        
      deferred income taxes
    		2,437,000 2,411,000 -20,728,000 -10,000 -50,000 -884,000 -15,719,000 5,813,000 2,122,000 -1,486,000 1,747,000 -2,242,000 -29,000 -275,000 -912,000 -6,025,000 -184,000 -7,413,000 -1,436,000 3,027,000 226,000 2,515,000 -4,131,000 744,000 -15,614,000 9,724,000 5,128,000 -2,771,000 3,151,000 -13,474,000 6,164,000 5,234,000 4,261,000 -5,378,000 4,796,000 -40,000 -390,000 -6,492,000 3,376,000 3,142,000 1,000 37,801,000 -1,285,000 -6,627,000 98,000 -35,037,000 -161,000 7,727,000 -20,152,000 -7,232,000 -1,030,000 3,453,000 2,786,000 1,275,000 337,000   
      share-based compensation
    		17,297,000 6,835,000 17,259,000 18,405,000 17,138,000 15,234,000 11,829,000 6,538,000 3,085,000 13,250,000 10,893,000 10,492,000 11,839,000  13,538,000 13,186,000 9,379,000             9,630,000                            
      loss on disposition of business operations and assets
    		16,000 26,000    64,000                 -79,000     -12,000 436,000                             
      equity method income
    		62,000 -1,046,000                                                        
      gain from sale of investments
    		  0 0 0 -277,000                                                    
      corporate-owned life insurance
    		734,000 655,000 689,000 1,052,000 975,000 695,000 1,949,000 -415,000 -808,000 878,000 -47,000 46,000                                              
      changes in assets and liabilities:
    		                                                         
      accounts receivable
    		12,325,000 -3,107,000 -20,206,000 10,559,000 912,000 -19,613,000 22,427,000 2,291,000 -9,434,000 -4,745,000 5,147,000 2,806,000 3,915,000 -11,733,000 -7,028,000 -2,221,000 12,476,000 -483,000 -2,801,000 7,816,000 12,764,000 4,597,000 -5,443,000 -12,809,000 -7,844,000 13,273,000 -5,236,000 -5,019,000 -4,471,000 8,591,000 -3,173,000 -7,775,000 -5,046,000 10,777,000 6,600,000 24,336,000 -16,359,000 9,022,000 -9,855,000 -6,746,000 4,611,000 7,813,000 6,449,000 -381,000 -11,054,000 3,644,000 4,433,000 -12,815,000 -264,000 9,970,000        
      inventories
    		-13,001,000 -6,627,000 -220,000 -7,415,000 -7,399,000 -3,632,000 15,677,000 19,537,000 -3,455,000 -727,000 712,000 -8,844,000 -6,425,000 -9,127,000 -819,000 -615,000 -3,923,000 -2,902,000 4,952,000 -1,580,000 -9,801,000 -2,310,000 -2,266,000 7,411,000 5,609,000 182,000 3,726,000 1,869,000 -11,292,000 -3,261,000 -72,000 38,000 1,336,000 7,568,000 9,029,000 -5,462,000 -873,000 -13,246,000 -5,860,000 854,000 4,962,000 11,944,000 5,953,000 -1,643,000 -4,016,000 -5,484,000 -2,193,000 1,947,000 1,479,000 116,000 2,086,000 923,000 -2,449,000 -4,562,000 -6,375,000 -3,545,000 466,000 
      other assets
    		-5,051,000 2,281,000 2,540,000 -3,108,000 -9,905,000 13,610,000 15,020,000 -2,024,000 1,334,000 -181,000 3,017,000 3,046,000 5,815,000 40,000 -11,311,000 -591,000 -3,207,000 5,078,000 4,287,000 -7,548,000 598,000 -1,964,000 -2,813,000 5,288,000 -1,098,000 -3,339,000 -1,519,000 -4,364,000 3,265,000                             
      accounts payable
    		1,420,000 9,805,000 -4,229,000 -12,173,000 12,031,000 19,053,000 -10,578,000 3,962,000 -9,106,000 5,802,000 -126,000 1,180,000 1,513,000 3,408,000 5,977,000 -2,960,000 -2,860,000 11,195,000 -6,336,000 -617,000 -1,639,000 2,214,000 2,703,000 -577,000 3,203,000 1,377,000 2,449,000 -4,985,000 -4,147,000 -3,674,000 3,605,000 1,353,000 1,817,000 4,303,000 -15,283,000 -5,653,000 21,613,000 -8,983,000 2,450,000 -1,192,000 -1,352,000 1,219,000 -10,034,000 -4,787,000 2,308,000 -924,000 7,721,000 1,663,000 -4,007,000 -9,933,000 2,120,000 600,000 3,859,000 -6,644,000 3,327,000 3,869,000 5,434,000 
      accrued liabilities
    		4,004,000 -15,444,000 4,190,000 17,847,000 -12,400,000 -14,260,000 -9,390,000 -37,916,000 4,897,000 24,038,000 -16,808,000 2,013,000 -14,659,000 317,000 1,449,000 6,009,000 -5,466,000 491,000 -1,966,000 10,117,000 -28,174,000 676,000 3,876,000 438,000 -6,852,000 10,282,000 -1,267,000 5,995,000 -12,536,000 1,697,000 3,815,000 6,745,000 -1,675,000 2,686,000 -6,278,000 -1,258,000 -8,095,000 1,800,000 2,378,000 8,876,000 -10,557,000 9,968,000 -2,567,000 1,147,000 -11,287,000 2,758,000 6,823,000 -2,182,000 -17,809,000 1,612,000 3,240,000 -1,828,000 -29,041,000 -465,000 14,182,000 3,506,000 -3,789,000 
      other liabilities
    		-3,337,000 -266,000 -10,404,000 -1,590,000 -1,697,000 -2,293,000 1,347,000 871,000 -1,759,000 -1,061,000 -1,469,000 -2,123,000 -4,188,000 -3,054,000 -1,388,000 2,643,000 -1,859,000 5,807,000 -488,000 -324,000 -1,371,000 -561,000 3,173,000 -2,686,000 -751,000 -15,016,000 666,000 53,000 2,124,000 -1,600,000 2,035,000 11,000 3,761,000 -798,000 -203,000 -1,532,000 3,078,000 5,453,000 -783,000 1,263,000 788,000 -2,547,000 1,290,000 2,213,000 2,392,000 1,320,000 2,435,000 462,000 863,000 347,000 -788,000 119,000 316,000 741,000 1,557,000 -685,000 1,337,000 
      net cash from operating activities
    		44,395,000 27,824,000 33,496,000 29,575,000 -4,995,000 -89,000 13,919,000 -5,847,000 18,181,000 77,278,000 50,051,000 50,986,000 32,585,000 27,254,000 28,377,000 37,216,000 26,083,000 45,255,000 33,268,000 33,352,000 6,741,000 47,198,000 51,998,000 49,338,000 35,029,000 38,635,000 26,854,000 35,637,000 10,359,000 32,918,000 39,227,000 31,666,000 13,801,000 34,460,000 18,870,000 34,049,000 14,697,000 11,631,000 33,392,000 38,368,000 22,769,000 30,597,000 28,939,000 41,295,000 17,150,000 35,189,000 54,908,000           
      cash flows from investing activities:
    		                                                         
      proceeds from sales of property, plant and equipment
    		  24,000 0   2,000 366,000    28,000 32,000 365,000 0   23,000 186,000 30,000 113,000 0 102,000 -17,000 27,000 9,000 174,000 0 6,000         18,000 0   0 0 49,000 8,000             
      purchase of property, plant and equipment
    		-2,884,000 -1,650,000 -2,633,000 -483,000 -3,411,000 -1,334,000 -1,712,000 -6,576,000 -7,060,000 -7,268,000 -8,315,000  -5,760,000 -10,926,000 -7,168,000 -6,968,000 -7,672,000 -2,647,000 -3,516,000 -1,635,000 -15,258,000 -4,124,000 -3,107,000 -4,886,000 -4,935,000 -8,643,000 -7,866,000 -13,777,000 -5,175,000 -19,166,000 -8,406,000 -2,635,000 -2,713,000 -2,321,000 -2,461,000 -3,403,000 -4,841,000 -6,296,000 -12,797,000 -6,283,000 -6,379,000 -6,411,000 -7,185,000 -12,815,000 -10,750,000 -5,151,000 -7,400,000           
      proceeds from sale of investments
    		0 536,000 0 0 0 2,650,000   0     51,000 0       4,366,000 0 0 1,601,000                                 
      purchase of investments
    		  0 0   0 0 -3,460,000 -1,288,000 -2,000,000  -2,927,000 0 -4,250,000 -2,800,000 -3,888,000 -2,038,000 -1,900,000 -7,067,000 -625,000 -2,596,000 -1,106,000 -105,000 -5,490,000 -5,328,000 -5,875,000 -2,712,000 -4,750,000                             
      purchase of intangibles
    		-2,250,000 -529,000 -393,000 -930,000 -3,692,000 -1,326,000 -1,144,000 -479,000                                                  
      proceeds from corporate-owned life insurance
    		  0 0 3,001,000 1,801,000 6,423,000 0 2,389,000 0 2,676,000                                               
      premiums paid for corporate-owned life insurance
    		0 -3,428,000       -2,389,000 0 -2,676,000 0                                              
      net cash from investing activities
    		-5,131,000 -5,071,000 -7,802,000 -1,413,000 -4,463,000 1,791,000 3,569,000 -6,689,000 -10,977,000 20,531,000 -10,315,000 -10,485,000 -8,655,000 -10,510,000 -11,418,000 -9,421,000 -11,560,000 -4,662,000 -5,230,000 -8,672,000 -15,770,000 -11,037,000 -4,055,000 -12,329,000 -8,797,000 -13,962,000 -7,867,000 -34,108,000 -9,919,000 -29,113,000 22,194,000 -3,883,000 -2,713,000 -11,721,000 -13,961,000 858,000 -42,003,000 -14,180,000 -13,181,000 -4,809,000 -8,922,000 -9,111,000 -6,684,000 -11,502,000 -6,641,000 -8,507,000 -13,166,000   30,098,000 32,882,000 -39,199,000 -9,881,000 -60,495,000 -6,863,000 -4,537,000 -11,381,000 
      cash flows from financing activities:
    		                                                         
      payments of term loans
    		-25,000,000 -10,000,000     0 -261,188,000          -101,250,000 -4,687,000 -4,687,000 -4,688,000 -4,688,000 -3,750,000 -3,750,000 -3,750,000 -3,750,000 -3,750,000 -3,750,000 -3,750,000                             
      proceeds from interest rate swap termination
    		                                                         
      deferred financing costs
    		-72,000 -492,000 0 0 0 -824,000 -7,549,000 -6,141,000      0 0 -6,000 -24,000                                         
      payments for employee share-based compensation payroll taxes
    		-3,290,000 -8,901,000 -6,728,000 -3,112,000 -1,760,000 -2,425,000 -1,238,000 -3,061,000                                                  
      proceeds from exercise of stock options
    		468,000 32,000 3,087,000 605,000 408,000 235,000   0 203,000 417,000 990,000 628,000 3,409,000 2,109,000 2,093,000 888,000 1,556,000 1,492,000 1,573,000 1,381,000 5,826,000 2,401,000 4,010,000 4,038,000 1,340,000 3,008,000 1,173,000 1,159,000                             
      distributions to noncontrolling interest
    		  0 0 0 -184,000                                                    
      net cash from financing activities
    		-27,657,000 -19,361,000 -9,603,000 -7,507,000 -1,352,000 -3,198,000 -13,787,000 -10,390,000 248,447,000 -10,843,000 -44,153,000 -37,499,000 -34,602,000 -10,124,000 -36,144,000 -15,286,000 -38,900,000 -30,326,000 -32,820,000 -24,143,000 -15,789,000 -36,277,000 -47,041,000 -29,024,000 -30,806,000 -7,875,000 -5,716,000 -5,225,000 -16,024,000 -4,610,000 -2,369,000 -4,925,000 -6,869,000 -3,288,000 -25,152,000 -33,809,000 8,482,000 391,000 -26,392,000 -36,046,000 -15,887,000 -15,685,000 -21,922,000 -23,161,000 -3,273,000 -8,444,000 -2,777,000 -4,934,000 341,304,000 -12,478,000 -23,311,000 10,938,000 19,126,000 8,110,000 13,575,000 1,260,000 4,950,000 
      effect of foreign exchange rate changes on cash and cash equivalents
    		479,000 1,339,000 -852,000 -79,000 -39,000 -312,000 1,064,000 -1,166,000                                                  
      net increase in cash and cash equivalents
    		12,086,000 4,731,000 15,239,000    4,765,000 -24,092,000 255,651,000   3,002,000      10,267,000 -4,782,000   -116,000 902,000   16,798,000 13,271,000 -3,696,000 -15,584,000 -805,000 59,052,000 22,858,000 4,219,000     -2,158,000 -6,181,000 -2,487,000 -2,040,000 5,801,000 333,000 6,632,000 7,236,000 18,238,000 39,096,000 26,957,000 -88,121,000 43,882,000 42,551,000 5,984,000 15,586,000 -23,190,000 36,291,000 23,551,000 1,769,000 
      cash and cash equivalents at beginning of period
    		0 151,743,000 0 0 0 128,585,000 0 0 0 0 279,601,000 0 268,891,000 0 0 0 293,324,000 0 0 0 312,120,000 0 0 0 307,923,000 0 0 0 297,134,000 0 0 0 211,810,000 0 0 0 230,328,000 0 0 0 243,194,000 0 0 0 223,192,000 0 0 0 227,022,000 0 0 0 119,019,000 0 0 0 80,598,000 
      cash and cash equivalents at end of period
    		12,086,000 156,474,000 15,239,000 20,576,000 -10,849,000 126,777,000 4,765,000 -24,092,000 255,651,000 86,966,000 275,184,000 3,002,000 258,219,000 6,620,000 -19,185,000 12,509,000 268,947,000 10,267,000 -4,782,000 537,000 287,302,000 -116,000 902,000 7,985,000 303,349,000 16,798,000 13,271,000 -3,696,000 281,550,000 -805,000 59,052,000 22,858,000 216,029,000 19,451,000 -20,243,000 1,098,000 211,504,000 -2,158,000 -6,181,000 -2,487,000 241,154,000 5,801,000 333,000 6,632,000 230,428,000 18,238,000 39,096,000 26,957,000 138,901,000 43,882,000 42,551,000 5,984,000 134,605,000 -23,190,000 36,291,000 23,551,000 82,367,000 
      supplemental disclosure of cash flow information:
    		                                                         
      interest paid
    		 3,526,000   25,205,000 17,147,000   8,336,000 944,000 987,000  1,065,000  2,312,000 1,094,000 1,570,000  2,293,000 2,136,000 2,212,000  1,805,000 1,971,000 1,929,000 1,144,000 1,707,000 1,681,000 1,809,000                             
      income taxes paid
    		 1,335,000   1,040,000 2,769,000   3,374,000 2,028,000 3,347,000  2,917,000  3,454,000 766,000 3,866,000  951,000 5,850,000 1,730,000  1,103,000 2,291,000 648,000 6,381,000 21,554,000 1,209,000 1,869,000                             
      non-cash investing and financing activities:
    		                                                         
      accounts payable related to capital expenditures
    		 247,000   -62,000 331,000   419,000 -424,000 3,808,000  2,355,000  2,042,000 -1,058,000 2,435,000                                         
      accrued deferred financing costs
    		 72,000                                                        
      accrued purchases of intangibles
    		 5,130,000                                                        
      right-of-use asset impairment
    		                                                         
      intangible impairment
    		                                                         
      accretion of deferred financing costs and debt discount
    		        279,000 120,000 121,000 120,000 121,000 120,000 120,000 121,000 121,000 119,000 118,000 122,000 125,000 129,000 130,000 133,000 136,000 138,000 141,000 143,000 146,000 129,000 160,000 164,000 168,000 415,000 394,000 347,000 313,000 294,000 278,000 261,000 250,000 254,000 245,000 250,000 760,000 726,000 738,000 753,000 328,000         
      write-off of deferred financing costs and debt discount
    		                                         0 -1,680,000               
      gain on disposition of business operations and assets
    		  138,000 33,000   267,000 -242,000                  -7,000                                
      equity method loss
    		       11,000                                                  
      amortization of inventory step-up
    		      0 0                                                  
      proceeds from sale of business, net of cash disposed
    		        -490,000                                                 
      acquisition, net of cash acquired
    		                      56,000                                   
      proceeds from revolving line of credit
    		      0 10,000,000 0 0 10,000,000 0                                              
      payments of revolving line of credit
    		  -278,250,000      -23,000,000   -4,000,000 -4,000,000 -4,000,000 -4,000,000 -4,000,000 -4,000,000                                         
      proceeds from term loans
    		                                                         
      proceeds from convertible senior notes
    		      0                                                   
      proceeds from sale of warrants
    		                                                         
      purchase of convertible note hedge
    		                                                         
      proceeds from issuance of common stock, net of issuance costs
    		                                                         
      repurchase of common stock
    		        0 0 -50,000,000 -32,746,000 -25,000,000 -5,000,000 -24,046,000 -12,387,000 -30,000,000 -27,583,000                                        
      accrued purchase of intangibles
    		                                                         
      debt extinguished in exchange for common stock
    		                                                         
      conversion of notes into equity
    		            626,000                                             
      equity method (income) loss
    		   12,000 0 -50,000                                                    
      net decrease in cash and cash equivalents
    		    -10,849,000 -1,808,000     -4,417,000  -10,672,000  -19,185,000 12,509,000 -24,377,000    -24,818,000    -4,574,000          -20,243,000 1,098,000 -18,824,000                     
      changes in the fair value of contingent earn-out obligations
    		             0 0 0 -33,000 -32,000                                        
      payments of earn-out
    		                 0                                        
      equity in net gains of equity method investments
    		        36,000 -283,000 -24,000 0                                              
      payment for employee share-based compensation payroll taxes
    		        -8,150,000 -1,046,000 -4,570,000  -6,230,000 -4,533,000 -10,207,000 -986,000 -5,764,000 -993,000 -7,113,000 -1,029,000 -12,372,000 -737,000 -7,162,000 -4,871,000 -5,769,000 -1,010,000 -4,974,000 -2,220,000 -3,467,000 -634,000                            
      (gain) loss on disposition of business operations and assets
    		                        -10,000                                 
      gain on disposition of assets
    		          8,000  -20,000        -106,000                                     
      (gain) loss on disposition of assets
    		              0                                           
      income taxes payable
    		                 0 0 0 -2,105,000 2,105,000 0 1,000 -1,698,000 1,802,000 -18,848,000 4,550,000 -3,222,000                           7,063,000 -7,907,000 
      purchases of property, plant and equipment
    		                                                -4,630,000 -3,557,000 -2,748,000 -7,790,000 -7,469,000 -7,521,000 -7,674,000 -5,856,000 -4,486,000 
      purchases of investments
    		                                                         
      contributions from noncontrolling interest
    		                 0                                        
      equity in net (gains) losses of equity method investments
    		            -78,000     0                                        
      corporate owned life insurance
    		            2,562,000 2,311,000 2,167,000 2,205,000 -175,000 2,255,000 2,602,000 -269,000 1,025,000 -75,000 -604,000 899,000 -254,000 758,000 289,000 306,000 248,000                             
      share-based compensation and warrant costs
    		                 23,308,000 8,767,000 8,646,000 11,328,000 12,912,000 11,466,000 13,965,000 35,516,000 3,770,000 15,356,000 15,524,000 13,286,000                             
      gain from sale of investment
    		                                                         
      acquisitions, net of cash acquired
    		                                 5,261,000 -9,500,000 0 -34,932,000         0 0 0 -491,717,000         
      equity in net incomees of equity method investments
    		               137,000 11,000   -168,000 411,000 85,000 -17,000 27,000 31,000 50,000                                
      supplemental disclosure of cash flow information
    		                                                         
      impairment of investments
    		                     0                                    
      gain from convertible debt settlement
    		                         0                                
      proceeds from convertible debt settlement
    		                         0                                
      deferred revenue
    		                  -1,119,000 -1,487,000 1,503,000 2,474,000 -435,000 127,000 -180,000 29,000 -251,000 -103,000 299,000 1,233,000 2,118,000 1,049,000 133,000 1,747,000 -9,000 -3,000 1,045,000 -2,011,000 1,432,000 733,000 -1,573,000 -273,000 2,142,000 281,000 1,251,000 -881,000 -1,545,000 576,000 738,000 -770,000 -1,079,000 790,000 -108,000 -190,000 1,274,000 483,000 177,000 
      decrease in accounts payable related to capital expenditures
    		                                                         
      loss on disposition of assets
    		                                                         
      earn-out liabilities
    		                   0 -2,161,000 0 -8,519,000   3,704,000    -53,000 0 -129,000 -33,000 -2,744,000 -14,186,000                       
      repurchase of outstanding common stock
    		                   -20,000,000 -110,000 -36,472,000 -30,000,000 -24,413,000 -25,325,000 -4,455,000 0 -428,000 -9,966,000 -466,000 0   0 -7,464,000 -29,833,000 -20,014,000 0 -20,906,000 -10,000,000 -10,000,000 -15,000,000    -7,500,000 0 -87,000 -182,000 -20,086,000 -30,028,000 -101,000 -450,000 -105,000 -1,312,000 -1,026,000 -376,000 
      non-cash items
    		                                                         
      capital expenditures in accounts payable
    		                   831,000 1,193,000  -136,000 260,000 2,054,000                                 
      contingencies
    		                           95,000 -50,000                             
      proceeds from disposition of business operations
    		                             -45,000                            
      payment of earn-out
    		                     -206,000                                    
      convertible debt
    		                           -1,000,000 2,175,000                             
      impairment of assets
    		                         0                                
      capital expenditures
    		                           391,000 1,511,000                             
      free cash flows
    		                           36,028,000 11,870,000                             
      intangible asset impairments
    		                                                         
      effect of acquisition fair value adjustments
    		                                         0 0 53,000 2,476,000 4,442,000 4,651,000           
      excess tax benefits on share-based compensation
    		                                                         
      proceeds from sales and maturities of available-for-sale investments
    		                                     550,000 0 2,624,000 500,000 750,000 501,000 1,000,000 7,998,000 7,767,000 1,500,000 14,607,000 88,592,000 36,626,000 45,118,000 27,421,000 22,583,000 31,026,000 31,693,000 23,433,000 24,835,000 
      purchase of intangible assets
    		                                     -100,000 0   -950,000 0 264,000 -2,847,000 -1,001,000    0        
      depreciation, amortization and impairments
    		                              11,619,000 11,961,000 11,926,000 12,398,000 12,514,000 11,980,000 12,040,000 33,056,000 12,217,000 12,026,000 12,004,000 51,687,000 13,449,000 15,591,000 13,346,000             
      environmental reserve
    		                              -2,000   0 0                       
      prepaid expenses and other assets
    		                              858,000 143,000 -12,786,000 -5,356,000 4,987,000 5,672,000 -4,684,000 -4,098,000 2,443,000 -3,012,000 -1,235,000 3,631,000 -3,054,000 1,230,000 -1,184,000 91,000 -421,000 2,189,000 4,112,000 1,047,000 -706,000 -6,227,000 -1,182,000 2,511,000 5,711,000 -6,375,000 -2,387,000 
      income taxes payable and prepaid taxes
    		                              -3,016,000 -2,204,000 -2,655,000 525,000 688,000 193,000 1,205,000 4,572,000 -256,000 -1,993,000 154,000 4,463,000 -1,249,000 -47,000 -1,342,000 26,574,000 -2,937,000 -20,356,000 -4,401,000 5,843,000 -1,222,000 1,661,000 -1,320,000     
      purchases of other investments
    		                              -2,000,000    -2,000,000 -1,000,000 -2,230,000                     
      proceeds from sale of equity investments
    		                                  0                       
      borrowings under line of credit
    		                                  0 0 35,000,000                     
      proceeds from exercises of stock options
    		                              710,000 754,000 214,000 1,842,000 997,000 1,183,000 1,785,000 928,000 1,977,000 4,190,000 1,785,000 -217,000 -2,235,000 5,976,000 2,352,000             
      payment of long term debt
    		                              0 -4,687,000 -4,687,000 -4,687,000 -16,688,000 -4,688,000 -4,687,000 -4,687,000 -4,687,000 -29,688,000 -4,687,000 -4,688,000 -4,688,000 -353,500,000 -5,625,000 -5,625,000 -5,625,000           
      stock-based compensation
    		                               6,097,000 5,707,000 7,070,000 5,116,000 2,336,000 5,946,000 8,573,000 7,935,000 6,274,000 6,847,000 2,979,000 6,828,000 6,156,000 8,626,000 7,801,000 6,482,000 4,919,000 5,326,000 6,871,000 5,041,000 4,621,000 7,487,000 6,085,000 7,419,000 7,206,000 8,300,000 
      loss on disposition of property, plant and equipment
    		                                               45,000 40,000   0 7,000  6,000 -12,000 75,000 
      payment for employee stock-based compensation payroll taxes
    		                               -453,000 -2,396,000  -1,997,000 -471,000 -3,602,000  -2,776,000 -548,000 -2,985,000                 
      adjustments to reconcile net income to net cash from operating activities, net of effects of acquisitions:
    		                                                         
      impairment - goodwill
    		                                                         
      excess tax benefits on stock based compensation
    		                                              -422,000 -1,071,000 -1,842,000 48,000 -608,000 -644,000 -1,075,000  -48,000 24,000 -257,000 
      gain on disposition of property, plant and equipment
    		                                       -16,000 2,000                 
      purchases of available-for-sale investments
    		                                         0 0 0 -1,050,000 -7,622,000 -7,016,000           
      purchase of cost method investment
    		                                     -3,500,000 -384,000 -221,000 -3,043,000                 
      proceeds from debt issuance, net of discount
    		                                         0 896,000   0 0           
      deferred financing cost
    		                                         0 -895,000   0 0 0 -8,962,000         
      payments for employee stock-based compensation payroll taxes
    		                                                         
      effect of exchange rate increase on cash and cash equivalents
    		                                             0 131,000 -236,000 170,000         
      payment for interest rate cap
    		                                             0 0           
      write off deferred financing costs & debt discount
    		                                                         
      proceeds of debt issue, net of discount
    		                                                347,000,000         
      (gain) loss on disposition of property, plant and equipment
    		                                         0 -1,000 -26,000 -1,000             
      payment on interest rate cap
    		                                                         
      depreciation, amortization and impairment
    		                                              12,755,000 1,249,000 21,296,000         
      accrued interest expense
    		                                              -41,000 -123,000 350,000         
      proceeds from issuance of common stock
    		                                              2,426,000    6,109,000       
      adjustments to reconcile net income to net cash from operations, net of effects of acquisitions:
    		                                                         
      net cash from operations
    		                                                -11,734,000 26,264,000 32,982,000 34,245,000 6,341,000 29,195,000 29,578,000 26,828,000 8,200,000 
      purchase of available-for-sale investments
    		                                                -10,106,000 -2,999,000 -6,501,000 -58,830,000 -25,000,000 -84,000,000 -30,907,000 -22,163,000 -31,732,000 
      proceeds from sale of property, plant and equipment
    		                                                 28,000 13,000 0 5,000 0 25,000 49,000 2,000 
      net cash (used in) investing activities
    		                                                -417,861,000         
      excess tax benefit received on stock options
    		                                                1,842,000         
      exercise of stock options
    		                                                1,606,000    18,501,000 7,605,000 14,839,000 2,310,000 5,069,000 
      adjustments to reconcile net income to net cash from operations:
    		                                                         
      impairment of acquired intangible assets
    		                                                 0        
      repayment of debt
    		                                                         
      effect of foreign currency translation on cash and cash equivalents
    		                                                         
      receivables
    		                                                   -901,000 208,000 8,301,000 -9,902,000 -9,165,000 -8,681,000 
      excess tax benefits
    		                                                         
      (gain) loss on disposition of property, plant and equipment and available for sale securities
    		                                                         
      insurance recovery
    		                                                         
      purchases of intangibles
    		                                                         
      effect of exchange rate changes on cash and cash equivalents
    		                                                         
      tax benefit on stock based compensation
    		                                                        760,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.